Search
News
Could a Drug Prevent Hearing Loss from Loud Music and Aging?
UCSF scientists have achieved a breakthrough in understanding what is happening in the inner ear during hearing loss, laying the groundwork for preventing deafness.
News
Nationally Recognized Health Equity Leader Appointed as Chair of UCSF Obstetrics and Gynecology Program
Andrea V. Jackson, MD, MAS, a highly regarded obstetrician, gynecologist and diversity champion, will draw on her experience in women’s reproductive health, training the next generation of caregivers and addressing systemic racism in her role as chair of UCSF Department of Obstetrics, Gynecology & Reproductive Sciences.
News
Study Finds Significant Chemical Exposures in Women With Cancer
In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies.
News
Inclusion of New Risk Factors Can Improve Prediction of Invasive Breast Cancer
UCSF researchers update Breast Cancer Surveillance Consortium model to account for BMI and other familial risk factors.
News
Focused Ultrasound Technology May Overcome Barrier to Brain Tumor Treatments
The blood-brain barrier protects the brain from many viruses, bacteria, and other harmful small molecules that could be circulating throughout the body. However, this same barrier prevents many cancer therapies from reaching brain tumors.
News
UCSF Cancer Researcher Thomas Martin Receives $4.6 million CIRM Grant
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell therapy for multiple myeloma, the second most common malignancy among blood cancers.
News
Prominent Orthopaedic Surgeon and Researcher to Lead UCSF Orthopaedics Program
C. Benjamin Ma, MD, a highly regarded orthopaedic surgeon and advanced imaging researcher, has been appointed as chair of the UCSF Department of Orthopaedic Surgery. Ma assumed his new role on January 1, 2024.
News
UCSF Health to Mark Thirty-Five Years of Heart Transplantation in 2024
In 2024, UC Health will celebrate 35 years of performing heart transplants. Since completing their first heart transplant in March 1989, UCSF surgeons have performed nearly 600, and along the way, the health system has become a recognized leader in treating heart failure and the sixth largest program for transplants in the nation.
News
Can Gene Expression Predict if a Brain Tumor Is Likely to Grow Back?
Screening tumors using this new approach could change the course of treatment for nearly 1 in 3 people with meningioma, the most common form of brain tumor diagnosed in 42,000 Americans each year.
News
Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities
While regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality, other women will be diagnosed with advanced breast cancer despite screening at regular intervals.
News
UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.
News
UCSF Research Vital to First Drug for Deadly Bone Disease
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation in place of soft and connective tissues.
News
Researchers Identify New Glucose Control Target That Could Lead to Novel Therapeutic Approaches
A 2017 study co-led by UCSF researchers found that a high-fat diet (HFD) is associated with the accumulation of inflammatory cells called microglia in the hypothalamus, which in turn increases the susceptibility of mice to overeat and gain excess weight.
News
Telehealth Referral Leads to Diagnosis and Effective Treatment of Rare Neuropathy: Case Study
A 68-year-old man from Hawaii with acetylcholine receptor (AChR) antibody–positive myasthenia gravis and poorly controlled type 2 diabetes complicated by neuropathy had been receiving intravenous immunoglobulin (IVIg) and taking pyridostigmine for two years when ...
News
Why Do Some Long Covid Patients Continue to Have Difficulty Exercising?
While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.
News
Can What Works to Treat Cancer Work for Diabetes?
To live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only treatment, subcutaneous insulin, is burdensome...
Document
Cancer Immunotherapy Toxicity Evaluation (CITE) Program
UCSF Health’s new Cancer Immunotherapy Toxicity Evaluation (CITE) Program is a valuable resource for both patient care and provider consults.
News
A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler
There is a major clinical unmet need for effective and safe therapies to increase progression-free and overall survival in older individuals with leukemia whose prognosis is grim.
News
Robotically Assisted, Completely Minimally Invasive Whipple Surgery: Case Study With Video
Since performing San Francisco’s first pure robotically assisted Whipple procedure in 2022, UCSF surgeons continue to be on the forefront of this technology, regularly performing robotic Whipple surgeries (pancreatoduodenectomies) on select patients.
News
UCSF Health Performs 150th Robotic Focal HIFU Procedure
UCSF is West Coast leader for the innovative, minimally invasive treatment for prostate cancer patients.
News
New Research on Optimizing UC Management Through Patient-Centered Tofacitinib Dosing
Tofacitinib is effective for managing ulcerative colitis (UC) and is linked to sustained steroid-free remission. The product label recommends dose de-escalation after eight or 16 weeks, but is this best for patients?
News
Deadly Dust: Engineered Stone Is Making California Workers Sick
Workers making artificial-stone slabs for the most popular type of countertops sold in the United States are developing a potentially deadly, irreversible lung disease from tiny particles of toxic dust, researchers from UC San Francisco and UCLA found...
News
Millions of Long-Term Smokers Have Lung Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those, chronic obstructive pulmonary disease (COPD)...
News
Novel Intraoperative Prostate Cancer Imaging Method Reveals Previously Undetectable Disease
UCSF researchers led the first-in-human study of a novel near-infrared fluorescence imaging agent that targets prostate-specific membrane antigen (PSMA).
